FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2807757932> ?p ?o ?g. }

• W2807757932 endingPage "24730" @default.
• W2807757932 startingPage "24718" @default.
• W2807757932 abstract "Certain lifestyles, such as unhealthy eating habits, are associated with an increased risk for several diseases, including cancer. Recently, some naturally occurring compounds, such as resveratrol, have been shown to regulate microRNA (miRNA) expression in a positive manner; this regulatory activity is likely to be advantageous for cancer prevention and treatment. Resveratrol, a multi-functional polyphenolic phytoalexin, has been known to exert anti-tumorigenic and anti-inflammatory effects and to regulate miRNA expression. However, our understanding of the underlying molecular mechanisms whereby resveratrol controls cancer cell growth via the regulation of miRNA and oncogenic target gene expression to inhibit disease progression remains incomplete. Here we show that resveratrol controls breast cancer cell proliferation by inducing tumor-suppressive miRNAs (miR-34a, miR-424, and miR-503) via the p53 pathway and then by suppressing heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1), which is associated with tumorigenesis and tumor progression. Notably, HNRNPA1 was directly regulated by miR-424 and miR-503, the expression of which were mediated by resveratrol. Moreover, we found that resveratrol exerts broad effects on the HNRNPA1-related pre-mRNA splicing pathway. Our data provide novel insights into the regulatory roles of resveratrol for preventing and treating of diseases." @default.
• W2807757932 created "2018-06-21" @default.
• W2807757932 creator A5006406850 @default.
• W2807757932 creator A5043415302 @default.
• W2807757932 creator A5054073408 @default.
• W2807757932 date "2018-05-15" @default.
• W2807757932 modified "2023-09-25" @default.
• W2807757932 title "Regulatory role of resveratrol, a microRNA-controlling compound, in <i>HNRNPA1</i> expression, which is associated with poor prognosis in breast cancer" @default.
• W2807757932 cites W1519433744 @default.
• W2807757932 cites W1607070363 @default.
• W2807757932 cites W1969208938 @default.
• W2807757932 cites W1970431885 @default.
• W2807757932 cites W1975308625 @default.
• W2807757932 cites W1978184244 @default.
• W2807757932 cites W1989059483 @default.
• W2807757932 cites W1994190235 @default.
• W2807757932 cites W1995539734 @default.
• W2807757932 cites W1997302711 @default.
• W2807757932 cites W2005789183 @default.
• W2807757932 cites W2022777430 @default.
• W2807757932 cites W2032541751 @default.
• W2807757932 cites W2035014104 @default.
• W2807757932 cites W2038167014 @default.
• W2807757932 cites W2044832480 @default.
• W2807757932 cites W2047088479 @default.
• W2807757932 cites W2048255587 @default.
• W2807757932 cites W2048448304 @default.
• W2807757932 cites W2049610541 @default.
• W2807757932 cites W2053835153 @default.
• W2807757932 cites W2054804513 @default.
• W2807757932 cites W2055313665 @default.
• W2807757932 cites W2059848983 @default.
• W2807757932 cites W2064420317 @default.
• W2807757932 cites W2066636886 @default.
• W2807757932 cites W2073576377 @default.
• W2807757932 cites W2074210527 @default.
• W2807757932 cites W2075798014 @default.
• W2807757932 cites W2077838973 @default.
• W2807757932 cites W2080644780 @default.
• W2807757932 cites W2083381199 @default.
• W2807757932 cites W2085934079 @default.
• W2807757932 cites W2088381487 @default.
• W2807757932 cites W2092690524 @default.
• W2807757932 cites W2098139456 @default.
• W2807757932 cites W2098208011 @default.
• W2807757932 cites W2103424665 @default.
• W2807757932 cites W2108053190 @default.
• W2807757932 cites W2110256992 @default.
• W2807757932 cites W2119337308 @default.
• W2807757932 cites W2121787561 @default.
• W2807757932 cites W2123188794 @default.
• W2807757932 cites W2127587768 @default.
• W2807757932 cites W2130979840 @default.
• W2807757932 cites W2134118500 @default.
• W2807757932 cites W2135314242 @default.
• W2807757932 cites W2144154026 @default.
• W2807757932 cites W2148929244 @default.
• W2807757932 cites W2149785901 @default.
• W2807757932 cites W2151089147 @default.
• W2807757932 cites W2155903397 @default.
• W2807757932 cites W2157936723 @default.
• W2807757932 cites W2158448236 @default.
• W2807757932 cites W2159103102 @default.
• W2807757932 cites W2159114297 @default.
• W2807757932 cites W2159482845 @default.
• W2807757932 cites W2160009291 @default.
• W2807757932 cites W2160968516 @default.
• W2807757932 cites W2174734928 @default.
• W2807757932 cites W2224319365 @default.
• W2807757932 cites W2295433490 @default.
• W2807757932 cites W2411771093 @default.
• W2807757932 cites W2559588208 @default.
• W2807757932 cites W2606523820 @default.
• W2807757932 cites W2621960348 @default.
• W2807757932 cites W4294216483 @default.
• W2807757932 cites W99740291 @default.
• W2807757932 doi "https://doi.org/10.18632/oncotarget.25339" @default.
• W2807757932 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5973863" @default.
• W2807757932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29872500" @default.
• W2807757932 hasPublicationYear "2018" @default.
• W2807757932 type Work @default.
• W2807757932 sameAs 2807757932 @default.
• W2807757932 citedByCount "50" @default.
• W2807757932 countsByYear W28077579322019 @default.
• W2807757932 countsByYear W28077579322020 @default.
• W2807757932 countsByYear W28077579322021 @default.
• W2807757932 countsByYear W28077579322022 @default.
• W2807757932 countsByYear W28077579322023 @default.
• W2807757932 crossrefType "journal-article" @default.
• W2807757932 hasAuthorship W2807757932A5006406850 @default.
• W2807757932 hasAuthorship W2807757932A5043415302 @default.
• W2807757932 hasAuthorship W2807757932A5054073408 @default.
• W2807757932 hasBestOaLocation W28077579321 @default.
• W2807757932 hasConcept C104317684 @default.
• W2807757932 hasConcept C121608353 @default.
• W2807757932 hasConcept C126322002 @default.
• W2807757932 hasConcept C145059251 @default.
• W2807757932 hasConcept C165864922 @default.

• next